Search

Leading the nation’s cancer advancements through research

Massey's nationally recognized research programs comprises nearly 150 research members discovering and developing a future without cancer.

Explore our programs

One of the Nation’s leading cancer research centers

VCU Massey Comprehensive Cancer Center is proud to be your local National Cancer institute (NCI)-designated Comprehensive Cancer Center. As one of just two centers in Virginia with this distinction, Massey is at the forefront of the nation’s cancer research efforts. Massey has been designated by the NCI since 1975 and received comprehensive status in 2023.

Learn more about Massey's quest for comprehensive designation

Preeminent research programs

Massey research members conduct cutting-edge research and lead collaborative initiatives through one of three scientific research programs.

Cancer Biology

Unraveling the causes of the growth and spread of cancer and identifying key interactions between tumors and their microenvironment

Developmental Therapeutics

Discovering, developing and evaluating novel, small molecules and biologics through clinical trials

Cancer Prevention & Control

Advancing cancer risk identification and mitigation as well as improved approaches to survivorship

Research events

Research events

Massey sponsors a range of research events for trainees and researchers.

Intramural funding

Intramural funding

Explore intramural funding opportunities for novel cancer-related research concepts.

Shared resources

Shared resources

Shared resources support the extensive cancer research portfolio of Massey scientists.

Related news

View all news

Research & Innovation

The integration of AI into cancer research and care

Sep 22, 2026

During VCU Massey's recent installment of the Director’s Distinguished Visiting Scholars Seminar Series (DDVSSS), Gregory Abel, M.D., MPH, spoke on the importance of exercising caution around the integration of artificial intelligence into cancer research and patient care. ...

Research & Innovation

VCU Massey researchers receive $2.5M NIH grant to inform breast, pancreatic cancer care

Sep 9, 2026

VCU Massey researchers were recently awarded a $2.5 million R01 grant from the National Cancer Institute. The five-year grant will allow Massey to evaluate the efficacy of TROP2 targeted antibody-drug conjugates (ADCs) to further enhance therapeutic benefits in both breast and pancreatic cancer care...